Whalesbook
Toh hua kya hai ki Prudent ka AUM baazi maar raha hai. Steady inflows aur acquisitions se inka asset base badh raha hai. March 2026 tak yeh ₹1.28 lakh crore tak pahunch gaya, pichhle saal ke muqable 25.74% ka jabardast jump! Yeh sab inke B2B2C partner platform ke wajah se ho raha hai, jahan yeh distributors ko jodte hain aur cost control karte hain.
Asset Growth mein Chhupi Chunautiyan
Inke portfolio ka 97% hissa equity mein hai. Haan, FY26 mein thoda AUM dip hua tha (1.6%) market ke fluctuations aur treasury losses ke karan, jisse Q4FY26 mein profit growth sirf 2.6% raha.
Insurance: Prudent ka Naya 'Growth Pillar'
Ab baat karte hain Prudent ke 'Second Pillar of Growth' yani insurance ki. Mutual fund distribution abhi bhi main revenue source hai (83.7%), lekin insurance se revenue FY26 mein 11.5% tak aa gaya hai, aur Q4FY26 mein toh 42% ki tezi dikhayi hai! Management ko umeed hai ki insurance aur baki products future mein mutual funds se bhi zyada grow karenge.
Regulatory Changes aur Prudent ka Response
Abhi ek chota sa panga SEBI ke naye Total Expense Ratio (TER) rules ka hai, jisme GST bhi TER mein include hoga. Company ka kehna hai ki yeh mostly revenue-neutral hoga, bas kuch 2-3 basis points ka impact aa sakta hai. Prudent ka model flexible hai, par regulations change hote rehte hain.
Competition aur High Valuation ka Pressure
Competition bhi kaafi hai. Groww aur Angel One jaise players market mein hain. Groww toh seedha consumers ko target kar raha hai. Prudent ka valuation dekha jaye toh 38x FY28 P/E par trade ho raha hai, jo kaafi high hai. FY26 mein 28.7% Return on Equity aur future mein 24% PAT CAGR ki expectation ke bawajood, stock price mein yeh sab already factored lagta hai.
Valuation Risk aur Aage ka Outlook
Is high valuation ka matlab hai ki future growth already stock price mein dikh raha hai. Direct mutual fund plans aur fintech platforms ki badhti popularity commission-based revenue ke liye threat hai. Regulatory changes ya commissions mein koi bhi adjustment profits ko affect kar sakti hai. Abhi analysts mostly 'Neutral' ya 'Hold' rating de rahe hain, aur target price ₹3,000-₹3,200 ke aas paas hai. Stock price volatility dikha raha hai, lekin AUM growth support kar raha hai. Management partners badhane aur insurance/other products expand karne par focus kar raha hai. Dekhna hoga ki yeh company apni high valuation maintain kar pati hai ya nahi, jabki competition aur regulatory landscape badal raha hai.